Back
Speaker illustration

undefined undefined undefined

Presentations

The follow-up of patients with chronic heart failure and implantable cardioverter defibrillator in primary prevention

Event: Heart Failure 2019

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Device Therapy

Access
Like
Thumbnail

The significance of NT-proBNP plasma concentration at baseline for predicting outcomes after CRT-D implantation in heart failure patients

Event: Heart Failure 2018

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac Resynchronization Therapy

Access
Like
Thumbnail

The impact of cardiac resynchronization therapy on serum levels of high sensitivity C-reactive protein in patients with chronic heart failure

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Results (Resynchronization therapy)

Session: Cardiac resynchronisation therapy

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources